Vascular endothelial growth factor (VEGF) fails to improve blood flow and to promote collateralization in a diabetic mouse ischemic hindlimb model

<p>Abstract</p> <p>Background</p> <p>Angiogenic therapy with vascular endothelial growth factor (VEGF) has been proposed as a treatment paradigm for patients suffering from an insufficiency of collateral vessels. Diabetes is associated with increase in the production of...

Full description

Bibliographic Details
Main Authors: Abassi Zaid A, Levy Nina S, Avivi Aaron, Nevo Eviatar, Rubinstein Irit, Nitecki Samy, Roguin Ariel, Sabo Edmond, Lache Orit, Frank Meira, Hoffman Aaron, Levy Andrew P
Format: Article
Language:English
Published: BMC 2003-12-01
Series:Cardiovascular Diabetology
Subjects:
Online Access:http://www.cardiab.com/content/2/1/18